Marcel Thalen

590 total citations
10 papers, 402 citations indexed

About

Marcel Thalen is a scholar working on Microbiology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Marcel Thalen has authored 10 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Microbiology, 5 papers in Epidemiology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Marcel Thalen's work include Bacterial Infections and Vaccines (9 papers), Pneumonia and Respiratory Infections (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Marcel Thalen is often cited by papers focused on Bacterial Infections and Vaccines (9 papers), Pneumonia and Respiratory Infections (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Marcel Thalen collaborates with scholars based in Netherlands, France and United States. Marcel Thalen's co-authors include Burt D. Ensley, Cüneyt M. Serdar, Coen Beuvery, J. Tramper, Camille Locht, Wim Jiskoot, Bert Zomer, Nathalie Mielcarek, Paul Roholl and Anne‐Sophie Debrie and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and The Journal of Infectious Diseases.

In The Last Decade

Marcel Thalen

10 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcel Thalen Netherlands 10 205 160 138 55 42 10 402
Reiko Ohki Japan 14 54 0.3× 59 0.4× 344 2.5× 42 0.8× 30 0.7× 20 558
Ana Sousa Manso United Kingdom 9 103 0.5× 167 1.0× 215 1.6× 56 1.0× 17 0.4× 9 499
Maria Loose Germany 11 22 0.1× 73 0.5× 99 0.7× 50 0.9× 25 0.6× 20 348
Wilfried Véron France 8 119 0.6× 26 0.2× 291 2.1× 37 0.7× 23 0.5× 9 500
Edson Luiz Folador Brazil 11 42 0.2× 64 0.4× 219 1.6× 25 0.5× 9 0.2× 22 347
Duangkamol Kunthalert Thailand 11 93 0.5× 60 0.4× 143 1.0× 23 0.4× 7 0.2× 28 347
Amar Madi France 8 81 0.4× 24 0.1× 214 1.6× 25 0.5× 19 0.5× 8 343
Sang Kyun Ahn Canada 11 28 0.1× 61 0.4× 222 1.6× 76 1.4× 41 1.0× 15 395
Mykhaylo O. Debelyy Germany 7 101 0.5× 66 0.4× 318 2.3× 36 0.7× 8 0.2× 8 425
James Lazenby United Kingdom 9 57 0.3× 19 0.1× 240 1.7× 38 0.7× 7 0.2× 16 384

Countries citing papers authored by Marcel Thalen

Since Specialization
Citations

This map shows the geographic impact of Marcel Thalen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Thalen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Thalen more than expected).

Fields of papers citing papers by Marcel Thalen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Thalen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Thalen. The network helps show where Marcel Thalen may publish in the future.

Co-authorship network of co-authors of Marcel Thalen

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Thalen. A scholar is included among the top collaborators of Marcel Thalen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Thalen. Marcel Thalen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Keech, Cheryl, Vicki E. Miller, Barbara Rizzardi, et al.. (2023). Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial. The Lancet. 401(10379). 843–855. 37 indexed citations
2.
Thalen, Marcel, Anne‐Sophie Debrie, Loïc Coutte, et al.. (2020). Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1. Vaccines. 8(3). 523–523. 9 indexed citations
3.
Lin, Ang, Danijela Apostolović, Maja Jahnmatz, et al.. (2020). Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans. Journal of Clinical Investigation. 130(5). 2332–2346. 39 indexed citations
4.
Locht, Camille, James F. Papin, Sophie Lecher, et al.. (2017). Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection. The Journal of Infectious Diseases. 216(1). 117–124. 59 indexed citations
5.
Thalen, Marcel, Arno van der Ark, Dennis W. Jansen, et al.. (2007). Improving the cellular pertussis vaccine: Increased potency and consistency. Vaccine. 26(5). 653–663. 22 indexed citations
6.
Thalen, Marcel, Luc Berwald, Bert Zomer, et al.. (2006). Fed-batch cultivation of Bordetella pertussis: Metabolism and Pertussis Toxin production. Biologicals. 34(4). 289–297. 10 indexed citations
7.
Thalen, Marcel, et al.. (2006). Effect of relevant culture parameters on Pertussis Toxin expression by Bordetella pertussis. Biologicals. 34(3). 213–220. 19 indexed citations
8.
Thalen, Marcel, Wim Jiskoot, Bert Zomer, et al.. (1999). Rational medium design for Bordetella pertussis: basic metabolism. Journal of Biotechnology. 75(2-3). 147–159. 75 indexed citations
9.
Westdijk, Janny, et al.. (1997). Quantification of Cell-Associated and Free Antigens inBordetella pertussisSuspensions by Antigen Binding ELISA. Journal of Immunoassay. 18(3). 267–284. 13 indexed citations
10.
Ensley, Burt D., et al.. (1993). Construction of Metabolic Operons Catalyzing the De Novo Biosynthesis of Indigo in Escherichia coli. Bio/Technology. 11(3). 381–386. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026